Cargando…

Heparin Cofactor II: A Novel Plausible Link of Obesity and Diabetes with Thrombosis

Detalles Bibliográficos
Autores principales:	Hasegawa, Yutaka, Ishigaki, Yasushi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Japan Atherosclerosis Society 2017
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5742364/ https://www.ncbi.nlm.nih.gov/pubmed/28794345 http://dx.doi.org/10.5551/jat.ED084

Ejemplares similares

MAFLD and ASCVD: Plasma Heparin Cofactor II Activity as an Anti-liver Fibrosis Biomarker
por: Shimabukuro, Michio
Publicado: (2023)

RNAi targeting heparin cofactor II promotes hemostasis in hemophilia A
por: Lin, Wen-yi, et al.
Publicado: (2021)

Migraine & paediatric obesity: a plausible link?
por: Ravid, Sarit
Publicado: (2014)

Plasma heparin cofactor II activity is inversely associated with albuminuria and its annual deterioration in patients with diabetes
por: Hara, Tomoyo, et al.
Publicado: (2021)

Linking dioxins to diabetes: epidemiology and biologic plausibility.
por: Remillard, Rene B J, et al.
Publicado: (2002)

Understanding Dermatan Sulfate−Heparin Cofactor II Interaction through Virtual Library Screening
por: Raghuraman, Arjun, et al.
Publicado: (2010)

Recombinant dermatan sulfate is a potent activator of heparin cofactor II-dependent inhibition of thrombin
por: Tykesson, Emil, et al.
Publicado: (2019)

The Role of Heparin Cofactor II in the Regulation of Insulin Sensitivity and Maintenance of Glucose Homeostasis in Humans and Mice
por: Kurahashi, Kiyoe, et al.
Publicado: (2017)

A Peptide of Heparin Cofactor II Inhibits Endotoxin-Mediated Shock and Invasive Pseudomonas aeruginosa Infection
por: Kalle, Martina, et al.
Publicado: (2014)

Acute Stent Thrombosis and Heparin Induced Thrombocytopenia: Another Manifestation of Kounis Syndrome?
por: Kounis, Nicholas G, et al.
Publicado: (2013)

Heparin: Heparin-induced thrombocytopenia and thrombosis: case report
Publicado: (2020)

Adiponectin Paradox More Evident in Non-Obese Than in Obese Patients with Diabetic Microvascular Complications
por: Satoh, Ken, et al.
Publicado: (2023)

A Hexasaccharide Containing Rare 2‐O‐Sulfate‐Glucuronic Acid Residues Selectively Activates Heparin Cofactor II
por: Sankarayanarayanan, Nehru Viji, et al.
Publicado: (2017)

The complete N-terminal extension of heparin cofactor II is required for maximal effectiveness as a thrombin exosite 1 ligand
por: Boyle, Amanda J, et al.
Publicado: (2013)

Parasitic pharmacology: A plausible mechanism of action for cannabidiol
por: Groeneveld, Geert Jan, et al.
Publicado: (2019)

Plasma Heparin Cofactor II Activity Is Inversely Associated with Hepatic Fibrosis of Non-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus
por: Hara, Tomoyo, et al.
Publicado: (2023)

Novel Antagonists of Heparin Binding Growth Factors
por: Cecchi, Fabiola, et al.
Publicado: (2012)

Perspective: Vitamin D deficiency and COVID‐19 severity – plausibly linked by latitude, ethnicity, impacts on cytokines, ACE2 and thrombosis
por: Rhodes, J. M., et al.
Publicado: (2020)

Heparin: Thrombocytopenia and thrombosis: case report
Publicado: (2021)

To heparinize or not to heparinize: Effect on arterial blood gas measurements
por: Lobo, Valentine
Publicado: (2014)

Aggregation Kinetics and Filament Structure of a Tau Fragment Are Influenced by the Sulfation Pattern of the Cofactor Heparin
por: Townsend, David, et al.
Publicado: (2020)

RUNX1 as a recombinase cofactor
por: Cieslak, Agata, et al.
Publicado: (2015)

Heparin cofactor II-thrombin complex and dermatan sulphate:chondroitin sulphate ratio are biomarkers of short- and long-term treatment effects in mucopolysaccharide diseases
por: Langford-Smith, Kia Jane, et al.
Publicado: (2010)

Plausibility or Honesty?
Publicado: (1890)

Pulmonary phthalate exposure and asthma - is PPAR a plausible mechanistic link?
por: Kocbach Bølling, Anette, et al.
Publicado: (2013)

Heparin: Haemorrhagic complications, deep vein thrombosis and heparin-induced thrombocytopenia: 7 case reports
Publicado: (2021)

Surviving Covid-19 with Heparin?
por: ten Cate, Hugo
Publicado: (2021)

Restimulating Interest in Cytomegalovirus as a Cofactor for HIV Infection
por: Emery, Vincent C.
Publicado: (2015)

Intra‐cardiac thrombosis in the setting of heparin‐induced thrombocytopenia
por: Mohamed, Amr
Publicado: (2021)

A Plausible Fallacy
por: Carleton, Edmund
Publicado: (1895)

Citrullination as a plausible link to periodontitis, rheumatoid arthritis, atherosclerosis and Alzheimer’s disease
por: Olsen, Ingar, et al.
Publicado: (2018)

A plausible link between the time-on-task effect and the sequential task effect
por: Mangin, Thomas, et al.
Publicado: (2022)

The efficacy and safety of low-molecular-weight heparin and unfractionated heparin in the treatment of cerebral venous sinus thrombosis
por: Afshari, Daryoush, et al.
Publicado: (2015)

Heparin-induced thrombocytopenia and thrombosis in a patient with Covid-19()
por: Huang, Ching-Tai, et al.
Publicado: (2020)

Advances in Heparins and Related Research. An Epilogue
por: Fareed, Jawed, et al.
Publicado: (2018)

Gut Microbiome and Its Cofactors Are Linked to Lipoprotein Distribution Profiles
por: Castro-Mejía, Josué L., et al.
Publicado: (2022)

Mathematics and plausible reasoning /
por: Polya, George, 1887-
Publicado: (1990)

Mathematics and plausible reasoning
por: Polya, George
Publicado: (1954)

Mathematics and plausible reasoning
por: Polya, George
Publicado: (1968)

Levels of biological plausibility
por: Love, Bradley C.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_a9vm6gj37ri77i9n5udvc1j9p3